Literature DB >> 21458552

Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.

Peng Liu1, Xinyu Rong, Johanna Laru, Bert van Veen, Juha Kiesvaara, Jouni Hirvonen, Timo Laaksonen, Leena Peltonen.   

Abstract

Nanosizing techniques are important tools for improving the bioavailability of water insoluble drugs. Here, a rapid wet milling method was employed to prepare nanosuspensions: 4 types of stabilizers at 4 different concentrations were tested on 2 structurally different drug compounds: indomethacin and itraconazole. Photon correlation spectroscopy (PCS) results showed that the finest nanosuspensions were obtained when 80 wt% (to drug amount) pluronic F68 was the stabilizer for indomethacin and 60 wt% pluronic F127 for itraconazole. Compared to physical mixtures, dissolution rates of the nanosuspensions showed significant increases. The morphology of nanoparticles was observed by transmission electron microscopy (TEM). Crystalline state of the drugs before and after milling was confirmed using differential scanning calorimetry (DSC) and X-ray powder diffraction (XRPD). The physical and chemical stabilities of the nanosuspensions after storage for 2 months at room temperature and at 4°C were investigated using PCS, TEM and HPLC. No obvious changes in particle size and morphology and no chemical degradation of the drug ingredients were seen.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21458552     DOI: 10.1016/j.ijpharm.2011.03.050

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  28 in total

1.  Dissolution studies of poorly soluble drug nanosuspensions in non-sink conditions.

Authors:  Peng Liu; Odile De Wulf; Johanna Laru; Teemu Heikkilä; Bert van Veen; Juha Kiesvaara; Jouni Hirvonen; Leena Peltonen; Timo Laaksonen
Journal:  AAPS PharmSciTech       Date:  2013-04-25       Impact factor: 3.246

2.  Interaction studies between indomethacin nanocrystals and PEO/PPO copolymer stabilizers.

Authors:  Peng Liu; Tapani Viitala; Alma Kartal-Hodzic; Huamin Liang; Timo Laaksonen; Jouni Hirvonen; Leena Peltonen
Journal:  Pharm Res       Date:  2014-08-22       Impact factor: 4.200

3.  NanoClusters surface area allows nanoparticle dissolution with microparticle properties.

Authors:  Christopher Kuehl; Nashwa El-Gendy; Cory Berkland
Journal:  J Pharm Sci       Date:  2014-04-30       Impact factor: 3.534

4.  Development of a nanocrystalline Paclitaxel formulation for HIPEC treatment.

Authors:  Lieselotte De Smet; Pieter Colin; Wim Ceelen; Marc Bracke; Jan Van Bocxlaer; Jean Paul Remon; Chris Vervaet
Journal:  Pharm Res       Date:  2012-05-04       Impact factor: 4.200

5.  Intact nanoparticulate indomethacin in fast-dissolving carrier particles by combined wet milling and aerosol flow reactor methods.

Authors:  Timo Laaksonen; Peng Liu; Antti Rahikkala; Leena Peltonen; Esko I Kauppinen; Jouni Hirvonen; Kristiina Järvinen; Janne Raula
Journal:  Pharm Res       Date:  2011-05-04       Impact factor: 4.200

6.  Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.

Authors:  Xingwang Zhang; Tianpeng Zhang; Yali Lan; Baojian Wu; Zhihai Shi
Journal:  AAPS PharmSciTech       Date:  2015-07-18       Impact factor: 3.246

7.  Transformation of Ritonavir Nanocrystal Suspensions into a Redispersible Drug Product via Vacuum Drum Drying.

Authors:  Barbara V Schönfeld; Ulrich Westedt; Benjamin-Luca Keller; Karl G Wagner
Journal:  AAPS PharmSciTech       Date:  2022-05-09       Impact factor: 3.246

8.  Structure and dissolution of L-leucine-coated salbutamol sulphate aerosol particles.

Authors:  Janne Raula; Jukka Seppälä; Jari Malm; Maarit Karppinen; Esko I Kauppinen
Journal:  AAPS PharmSciTech       Date:  2012-05-05       Impact factor: 3.246

9.  Enhanced Dermal Delivery of Flurbiprofen Nanosuspension Based Gel: Development and Ex Vivo Permeation, Pharmacokinetic Evaluations.

Authors:  Ayse Nur Oktay; Sibel Ilbasmis-Tamer; Orhan Uludag; Nevin Celebi
Journal:  Pharm Res       Date:  2021-06-04       Impact factor: 4.200

10.  3D Printing of Drug Nanocrystals for Film Formulations.

Authors:  Giorgia Germini; Leena Peltonen
Journal:  Molecules       Date:  2021-06-28       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.